Una herramienta informática analiza en detalle las alteraciones genéticas del genoma de las células cancerosas

by CSIC - Centro Superior de Investigaciones Científicas

Desarrollada por el CSIC, CiberAMP permite establecer correlaciones directas entre cambios en el número de copias de genes en las células tumorales y sus niveles de expresión

Read more

Adjuvant monotherapy with nivolumab provides better outcomes than combining it with ipilimumab in hih-risk melanoma

by VHIO

In the CheckMate 915 study, it has been possible to see that in the adjuvant treatment of high-risk melanoma in stage IIIA-D or resected stage IV, the use of nivolumab as monotherapy is as effective a...

Read more

Launch of the European project ColoMARK, in which IDIBAPS is a partner

by Fundació Clínic per a la Recerca Biomèdica

Meritxell Gironella will lead the Institute's contribution to the project, which is financed by Horizon Europe funding from the European Union’s Marie Sklodowska-Curie Actions programme. The project...

Read more

An ibs.GRANADA investigation identifies genes that allow advances in lymphoma treatment

by Instituto de Investigación Biosanitaria - Ibs Granada

The finding, on which the team led by Pedro Medina from the Center for Genomics and Oncology Research (GENYO) has been working since 2014, focuses on mutations that to date had gone unnoticed by the s...

Read more

El Hospital del Mar incorpora el mapeo óptico del genoma para el diagnóstico y estudio genético de personas con enfermedades genéticas, tumores y cánceres hematológicos

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Se trata de una técnica que permite a los genetistas analizar fragmentos muy grandes de ADN y detectar un número de alteraciones genómicas muy superior a las que se pueden ver con el resto de técn...

Read more

A UB research group furthers the customisation of the treatment for atopic dermatitis

by Fundació Bosch i Gimpera

Researchers in dermatology and human chronic inflammation, has led a new study focusing on the molecular mechanisms of moderate-severe forms of the atopic dermatitis disease. They have identified diff...

Read more

'Advanced Therapies are the medicine of the future': Mercedes Zurita, researcher and head of the Cell Therapy Unit at Puerta de Hierro Hospital

by Sermes CRO

Interview Dr. Mercedes Zurita, researcher at the Puerta de Hierro Hospital and head of the Cell Therapy Unit at this site, the only one in Spain to offer NC1 therapy for patients with spinal cord inju...

Read more

A study in animal models identifies genetic markers involved in memory alterations associated with Huntington’s disease

by Fundació Clínic per a la Recerca Biomèdica

The study, led by researchers from IDIBAPS and the University of Barcelona, shows that these modifications play a role in the deregulation of genes associated with the function of neuronal synapses

Read more

Simultaneous initiation of antiretroviral therapy and immunotherapy leads to better HIV control

by IrsiCaixa

A study with the participation of IrsiCaixa and published in the journal Nature Medicine shows that starting the administration of an anti-HIV antibody and antiretroviral treatment at the same time wo...

Read more

Alterations in genetic transcription related to respiratory sequelae derived from severe COVID identified

by IRB Lleida. Institut de Recerca Biomèdica

Researchers focused on the search for new molecular information associated with the respiratory consequences of severe COVID-19 symptoms that progressed to acute respiratory distress syndrome (ARDS)....

Read more

Publican el primer modelo de ratón de carcinomas escamosos de cabeza y cuello en anemia de Fanconi

by CIBERER - Centro de Investigación Biomédica en Red de Enfermedades Raras

El equipo de investigación de Ramón García-Escudero, perteneciente al grupo Jesús M. Paramio del programa Mecanismos de Progresión Tumoral del CIBERONC ha publicado el primer modelo animal de car...

Read more

Xeltis presented promising FIH data on restorative hemodialysis access graft at PVC congress

by Ysios Capital

Xeltis, a medtech company developing the most advanced polymer-based restorative cardiovascular devices, today announced very promising preliminary efficacy and safety results from one of the centers ...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream